This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Comparisons With Neuroleptics

Frederick K. Goodwin, MD; Athanasios P. Zis, MD, FRCP(C)

Arch Gen Psychiatry. 1979;36(8):840-844.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since the original discovery of the antimanic properties of lithium nearly 30 years ago,¹ a large number of studies, as well as extensive clinical experience, have confirmed the efficacy of this drug for the treatment of the manic phase of manic-depressive illness. The recent focus of questions concerning the role of lithium in the treatment of mania has shifted from efficacy per se to comparisons with other drug treatments and the related issue of specificity. This review will, therefore, focus on controlled studies comparing lithium with neuroleptics, following a brief historical review of the earlier studies. The studies comparing lithium with neuroleptics are of special importance not only from a practical point of view but also theoretically, in that they bear on the question of the specificity of lithium against the manic syndrome—a question with implication for the underlying pathophysiology of mania.

OPEN SINGLE-BLIND STUDIES

Table 1 summarizes the . . . [Full Text PDF of this Article]

Author Affiliations
From the Clinical Psychobiology Branch, National Institute of Mental Health, Bethesda, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?